By this letter, we aimed to address the need of an adequate assessment of functional status in post‐intensive care unit (ICU) coronavirus disease 2019 (COVID‐19) patients. COVID‐19 patients are at risk for post intensive care syndrome, with an impaired functional status. Physical and Rehabilitation Medicine (PRM) physicians have to face both acute and post-acute COVID‐19 patients and provide them with an adequate respiratory and neuromotor rehabilitation plan. To date, specific assessment tools are warranted to provide information regarding COVID‐19 patients' functioning.
Chelsea Critical Care Physical Assessment Tool (CPAx) is a bedside assessment tool specifically designed to assess function in post‐ICU patients and has demonstrated validity, reliability, and responsiveness in critical care population. Taken together, we retain that the CPAx, due to its characteristics, might be used by PRM physicians for assessing functioning in post‐ICU COVID‐19 patients. COVID‐19 pandemic has reached more than 96.2 million of cases and more than 2 million of deaths at the moment of writing, putting under heavy stress health systems worldwide, especially ICUs. COVID‐19 survivors are at risk for post intensive care syndrome, including ICU‐acquired weakness and a consequent impairment in terms of functioning.